Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
They are prepared by licensed compounding pharmacies under physician prescription and have not been evaluated through clinical trials for safety, efficacy, or therapeutic equivalence to any FDA-approved medications
Key Clinical Findings Statistically significant improvement in sexual desire versus placebo Significant reduction in distress related to low desire Effects maintained throughout 24-week study period Approximately 25% of patients reported meaningful improvement in satisfying sexual events Nausea was the most common side effect (40%) but typically decreased over time Research in Male Sexual Dysfunction Before development focused on female HSDD, PT-141 was extensively studied in men with erectile dysfunction
Unfortunately the SFI could not be calculated by the research team as there was poor toe to toe print separation
Compounded semaglutide may pose safety, quality, and dosing risks because it does not undergo the FDAs review for safety, effectiveness, or manufacturing standards
US$ 24.81
US$ 20.43
US$ 26.75
US$ 27.36
US$ 24.24
US$ 24.60
US$ 21.86
